Literature DB >> 16369306

Pregnancy and other factors associated with higher CD4+ T-cell counts at HIV diagnosis in Southeast Michigan, 1992-2002.

Linda L Wotring1, JoLynn P Montgomery, Eve D Mokotoff, Joseph N Inungu, Norman Markowitz, Lawrence R Crane.   

Abstract

BACKGROUND: Early diagnosis of HIV infection provides the opportunity for treatment to prevent progression to AIDS and for intervention to prevent further transmission. The impact of routine screening of pregnant women and other factors on the stage of HIV disease at diagnosis were evaluated.
METHODS: Data were collected in 1992-2002 from the medical records of persons presenting for HIV-related care at 2 major medical centers in Detroit, Michigan. Patients were included in the analysis if they had a CD4+ T-cell count recorded within 6 months of their first positive HIV test (N = 1858).
RESULTS: Half of the patients (49%) had a first CD4+ T-cell count of < 200 cells/mm3 and 19% had an AIDS-defining illness at the time of HIV diagnosis. In the multivariate model, pregnant women were less likely than nonpregnant women to enter care with a CD4+ T-cell count of < 200 cells/mm3 (odds ratio, .24; 95% confidence interval, .14-.41). Even after adjusting for pregnancy, female sex was protective, as was age < 30 years. HIV-transmission risk factors, race, and time period of HIV diagnosis were not significantly associated with first CD4+ T-cell counts of < 200 cells/mm3.
CONCLUSION: Routinely offering HIV testing in prenatal care, as required by Michigan law, resulted in earlier diagnoses of HIV in pregnant women, as indicated by their higher CD4+ T-cell counts. Increasing routine HIV testing of all persons seeking medical care may increase the overall proportion of HIV diagnoses that are made early in the disease process.

Entities:  

Mesh:

Year:  2005        PMID: 16369306      PMCID: PMC1681393     

Source DB:  PubMed          Journal:  MedGenMed        ISSN: 1531-0132


  36 in total

1.  An analysis of the serostatus approach to fighting the HIV epidemic.

Authors:  Joseph N Inungu
Journal:  Am J Public Health       Date:  2002-03       Impact factor: 9.308

2.  HIV-related morbidity and mortality in patients starting protease inhibitors in very advanced HIV disease (CD4 count of < 50 cells/microL): an analysis of 338 clinical events from a randomized clinical trial.

Authors:  M Floridia; V Fragola; C M Galluzzo; G Giannini; M F Pirillo; M Andreotti; C Tomino; S Vella
Journal:  HIV Med       Date:  2002-04       Impact factor: 3.180

3.  CD4 cell counts in adults with newly diagnosed HIV infection: results of surveillance in England and Wales, 1990-1998. CD4 Surveillance Scheme Advisory Group.

Authors:  S B Gupta; R L Gilbert; A R Brady; S J Livingstone; B G Evans
Journal:  AIDS       Date:  2000-05-05       Impact factor: 4.177

4.  The impact of pregnancy and menopause on CD4 lymphocyte counts in HIV-infected women.

Authors:  Birgit H B van Benthem; Pietro Vernazza; Roel A Coutinho; Maria Prins
Journal:  AIDS       Date:  2002-04-12       Impact factor: 4.177

5.  A study of sex differences in presentation for care of HIV.

Authors:  C L Biber; M A Jaker; P Kloser; S B Auerbach; G G Rhoads
Journal:  AIDS Patient Care STDS       Date:  1999-02       Impact factor: 5.078

6.  Pregnancy and progression to AIDS: results of the French prospective cohorts. SEROGEST and SEROCO Study Groups.

Authors:  M Saada; J Le Chenadec; A Berrebi; A Bongain; J F Delfraissy; M J Mayaux; L Meyer
Journal:  AIDS       Date:  2000-10-20       Impact factor: 4.177

7.  Identifying undiagnosed human immunodeficiency virus: the yield of routine, voluntary inpatient testing.

Authors:  Rochelle P Walensky; Elena Losina; Kathleen A Steger-Craven; Kenneth A Freedberg
Journal:  Arch Intern Med       Date:  2002-04-22

8.  Immunological markers in HIV-infected pregnant and non-pregnant women.

Authors:  A Vimercati; P Greco; P L Lopalco; G Loverro; J R Fiore; S Bettocchi; G Angarano; L Selvaggi
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2000-05       Impact factor: 2.435

9.  The extent of HIV-1-related immunodeficiency and age predict the long-term CD4 T lymphocyte response to potent antiretroviral therapy.

Authors:  Gilbert R Kaufmann; Mark Bloch; Robert Finlayson; John Zaunders; Don Smith; David A Cooper
Journal:  AIDS       Date:  2002-02-15       Impact factor: 4.177

10.  Evaluation of initial CD4+ T cell counts in individuals with newly diagnosed human immunodeficiency virus infection, by sex and race, in urban settings.

Authors:  Mark Dybul; Robert Bolan; David Condoluci; Roxane Cox-Iyamu; Robert Redfield; Claire W Hallahan; Marlene Folino; Kunthavi Sathasivam; Monica Weisberg; Maryann Andrews; Bertha Hidalgo; Joshua Vasquez; Anthony S Fauci
Journal:  J Infect Dis       Date:  2002-05-31       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.